{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:32:15Z","timestamp":1787243535459,"version":"build-2736575974"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,2,26]],"date-time":"2020-02-26T00:00:00Z","timestamp":1582675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"University of Sydney Lifespan Research Network"},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"publisher","award":["APP1113532"],"award-info":[{"award-number":["APP1113532"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Australian Government Research Training Program"},{"DOI":"10.13039\/501100007811","name":"Sydney Medical School Foundation Scholarship","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007811","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,3,27]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>STUDY QUESTION<\/jats:title>\n                    <jats:p>What are clinicians\u2019 views about the diagnosis of polycystic ovary syndrome (PCOS), and how do they handle any complexities and uncertainties in practice?<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>SUMMARY ANSWER<\/jats:title>\n                    <jats:p>Clinicians have to navigate many areas of complexity and uncertainty regarding the diagnosis of PCOS, related to the diagnostic criteria, limitations in current evidence and misconceptions surrounding diagnosis, and expressed concern about the risk and consequences of both under- and overdiagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WHAT IS KNOWN ALREADY<\/jats:title>\n                    <jats:p>PCOS is a complex, heterogeneous condition with many areas of uncertainty, raising concerns about both underdiagnosis and overdiagnosis. Quantitative studies with clinicians have found considerable variation in diagnostic criteria used and care provided, as well as a lack of awareness around the breadth of PCOS features and poor uptake of recommended screening for metabolic complications. Clinicians\u2019 views about the uncertainties and complexities of diagnosing PCOS have not been explored.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY DESIGN, SIZE, DURATION<\/jats:title>\n                    <jats:p>Semi-structured telephone interviews were conducted with clinicians from September 2017 to July 2018 to explore their perceptions about the diagnosis of PCOS, including how they handle any complexities and uncertainties in practice.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PARTICIPANTS\/MATERIALS, SETTING, METHODS<\/jats:title>\n                    <jats:p>A group of 36 clinicians (15 general practitioners, 10 gynaecologists and 11 endocrinologists) currently practicing in Australia, were recruited through advertising via professional organisations, contacting a random sample of endocrine and gynaecology teams across Australia and snowballing. Transcribed audio-recordings were analysed thematically using Framework analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>MAIN RESULTS AND THE ROLE OF CHANCE<\/jats:title>\n                    <jats:p>Clinicians expressed a range of uncertainties and complexities regarding the diagnosis of PCOS, which were organised into three areas: (i) establishing diagnosis (e.g. lack of standardisation regarding diagnostic cut-offs, risk of misdiagnosis), (ii) factors influencing the diagnostic process (e.g. awareness of limitations in evidence and consideration of the benefits and harms) and (iii) strategies for handling challenges and uncertainties (e.g. using caution and communication of uncertainties). Clinicians also varied in their concerns regarding under- and overdiagnosis. Overall, most felt the diagnosis was beneficial for women provided that it was the correct diagnosis and time was taken to assess patient expectations and dispel misconceptions, particularly concerning fertility.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>LIMITATIONS, REASONS FOR CAUTION<\/jats:title>\n                    <jats:p>There is possible selection bias, as clinicians who are more knowledgeable about PCOS may have been more likely to participate. Clinicians\u2019 views may also differ in other countries.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>WIDER IMPLICATIONS OF THE FINDINGS<\/jats:title>\n                    <jats:p>These findings underscore the vital need to first consider PCOS a diagnosis of exclusion and use caution before giving a diagnosis in order to reduce misdiagnosis, as suggested by clinicians in our study. Until there is greater standardisation of diagnostic criteria, more transparent conversations with women may help them understand the uncertainties surrounding the criteria and limitations in the evidence. Additionally, clinicians emphasised the importance of education and reassurance to minimise the potential harmful impact of the diagnosis and improve patient-centred outcomes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>STUDY FUNDING\/COMPETING INTEREST(S)<\/jats:title>\n                    <jats:p>The study was funded by the University of Sydney Lifespan Research Network and an NHMRC Program Grant (APP1113532). T.C. is supported by an Australian Government Research Training Program (RTP) Scholarship and a Sydney Medical School Foundation Scholarship, from the The University of Sydney, Australia. B.W.M. reports consultancy for ObsEva, Merck, Merck KGaA and Guerbet. No further competing interests exist.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>TRIAL REGISTRATION NUMBER<\/jats:title>\n                    <jats:p>N\/A<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humrep\/deaa005","type":"journal-article","created":{"date-parts":[[2020,1,15]],"date-time":"2020-01-15T07:10:47Z","timestamp":1579072247000},"page":"660-668","source":"Crossref","is-referenced-by-count":33,"title":["Clinicians\u2019 perspectives on diagnosing polycystic ovary syndrome in Australia: a qualitative study"],"prefix":"10.1093","volume":"35","author":[{"given":"T","family":"Copp","sequence":"first","affiliation":[{"name":"Wiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"},{"name":"Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D M","family":"Muscat","sequence":"first","affiliation":[{"name":"Wiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"},{"name":"Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hersch","sequence":"first","affiliation":[{"name":"Wiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"},{"name":"Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K J","family":"McCaffery","sequence":"first","affiliation":[{"name":"Wiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"},{"name":"Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Doust","sequence":"first","affiliation":[{"name":"Wiser Healthcare, Centre for Research in Evidence-Based Practice, Bond University, Robina, 4226, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B W","family":"Mol","sequence":"first","affiliation":[{"name":"Department of Obstetrics and Gynaecology, Monash University, Clayton, 3800, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Dokras","sequence":"first","affiliation":[{"name":"Penn PCOS Centre, Department of Obstetrics and Gynaecology, University of Pennsylvania, Philadelphia, PA 19104, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Jansen","sequence":"first","affiliation":[{"name":"Wiser Healthcare, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"},{"name":"Sydney Health Literacy Lab, Sydney School of Public Health, Faculty of Medicine and Health, The University of Sydney, Sydney 2006, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,2,26]]},"reference":[{"key":"2020033016151233900_ref1","first-page":"371","article-title":"Screening for insulin resistance in polycystic ovary syndrome: views of physician members of the American society for reproductive medicine","volume":"60","author":"Asante","year":"2015","journal-title":"J Reprod Med"},{"key":"2020033016151233900_ref2","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/jc.2005-2153","article-title":"Controversy in clinical endocrinology: diagnosis of polycystic ovarian syndrome: the Rotterdam criteria are premature","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020033016151233900_ref3","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1038\/nrdp.2016.57","article-title":"Polycystic ovary syndrome","volume":"2","author":"Azziz","year":"2016","journal-title":"Nat Rev Dis Primers"},{"key":"2020033016151233900_ref4","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"2020033016151233900_ref5","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EJE-14-0252","article-title":"European survey of diagnosis and management of the polycystic ovary syndrome: results of the ESE PCOS Special Interest Group\u2019s Questionnaire","volume":"171","author":"Conway","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"2020033016151233900_ref6","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoz026","article-title":"The benefits and harms of receiving a polycystic ovary syndrome diagnosis: a qualitative study of women\u2019s experiences","volume":"2019","author":"Copp","year":"2019","journal-title":"Hum Reprod Open"},{"key":"2020033016151233900_ref7","doi-asserted-by":"crossref","first-page":"j3694","DOI":"10.1136\/bmj.j3694","article-title":"Are expanding disease definitions unnecessarily labelling women with polycystic ovary syndrome?","volume":"358","author":"Copp","year":"2017","journal-title":"BMJ"},{"key":"2020033016151233900_ref8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2265.2004.02208.x","article-title":"Polycystic ovarian syndrome: marked differences between endocrinologists and gynaecologists in diagnosis and management","volume":"62","author":"Cussons","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020033016151233900_ref9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2014.08.001","article-title":"Cardiovascular and metabolic profiles amongst different polycystic ovary syndrome phenotypes: who is really at risk?","volume":"102","author":"Daan","year":"2014","journal-title":"Fertil Steril"},{"key":"2020033016151233900_ref10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.ajog.2016.07.043","article-title":"Metabolic screening in patients with polycystic ovary syndrome is largely underutilized among obstetrician-gynecologists","volume":"215","author":"Dhesi","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2020033016151233900_ref11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1210\/er.2011-1034","article-title":"Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications","volume":"33","author":"Diamanti-Kandarakis","year":"2012","journal-title":"Endocr Rev"},{"key":"2020033016151233900_ref12","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.fertnstert.2017.04.011","article-title":"Gaps in knowledge among physicians regarding diagnostic criteria and management of polycystic ovary syndrome","volume":"107","author":"Dokras","year":"2017","journal-title":"Fertil Steril"},{"key":"2020033016151233900_ref13","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1210\/jc.2013-4190","article-title":"Are young adult women with polycystic ovary syndrome slipping through the healthcare cracks?","volume":"99","author":"Dokras","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"2020033016151233900_ref14","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"2020033016151233900_ref15","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1007\/s12160-017-9895-z","article-title":"Can communicating personalised disease risk promote healthy behaviour change? A systematic review of systematic reviews","volume":"51","author":"French","year":"2017","journal-title":"Ann Behav Med"},{"key":"2020033016151233900_ref16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1055\/s-0038-1667155","article-title":"Knowledge and practices regarding polycystic ovary syndrome among physicians in Europe, North America, and internationally: an online questionnaire-based study","volume":"36","author":"Gibson-Helm","year":"2018","journal-title":"Semin Reprod Med"},{"key":"2020033016151233900_ref17","first-page":"604","article-title":"Delayed diagnosis and a lack of information associated with dissatisfaction in women with polycystic ovary syndrome","volume":"102","author":"Gibson-Helm","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2020033016151233900_ref18","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJM197810052991403","article-title":"Increased absenteeism from work after detection and labeling of hypertensive patients","volume":"299","author":"Haynes","year":"1978","journal-title":"N Engl J Med"},{"key":"2020033016151233900_ref19","doi-asserted-by":"crossref","first-page":"i1102","DOI":"10.1136\/bmj.i1102","article-title":"The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis","volume":"352","author":"Hollands","year":"2016","journal-title":"BMJ"},{"key":"2020033016151233900_ref20","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/j.fertnstert.2016.07.1121","article-title":"Phenotypes and body mass in women with polycystic ovary syndrome identified in referral versus unselected populations: systematic review and meta-analysis","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"2020033016151233900_ref21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.fertnstert.2016.05.003","article-title":"Criteria, prevalence, and phenotypes of polycystic ovary syndrome","volume":"106","author":"Lizneva","year":"2016","journal-title":"Fertil Steril"},{"key":"2020033016151233900_ref22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0140-6736(17)33324-X","article-title":"Changing minds about changing behaviour","volume":"391","author":"Marteau","year":"2018","journal-title":"Lancet"},{"key":"2020033016151233900_ref23","volume-title":"Evidence-based Methodology Workshop on Polycystic Ovary Syndrome","author":"National Institutes of Health","year":"2012"},{"key":"2020033016151233900_ref24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jpag.2014.03.002","article-title":"Trends in standard workup performed by pediatric subspecialists for the diagnosis of adolescent polycystic ovary syndrome","volume":"28","author":"Powers","year":"2015","journal-title":"J Pediatr Adolesc Gynecol"},{"key":"2020033016151233900_ref25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.4324\/9780203413081_chapter_9","volume-title":"Analysing Qualitative Data","author":"Ritchie","year":"1994"},{"key":"2020033016151233900_ref26","first-page":"219","volume-title":"Qualitative Research Practice: A Guide for Social Science Students and Researchers","author":"Ritchie","year":"2003"},{"key":"2020033016151233900_ref27","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1542\/peds.2012-3070","article-title":"Influence of \u201cGERD\u201d label on parents\u2019 decision to medicate infants","volume":"131","author":"Scherer","year":"2013","journal-title":"Pediatrics"},{"key":"2020033016151233900_ref28","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/2372732218786042","article-title":"Too much medicine: Behavioural science insights on overutilisation, overdiagnosis and overtreatment in healthcare","volume":"5","author":"Shaffer","year":"2018","journal-title":"Policy Insights from the Behavioural and Brain Sciences"},{"key":"2020033016151233900_ref29","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1055\/s-0037-1603581","article-title":"Hypothalamic amenorrhea and the long-term health consequences","volume":"35","author":"Shufelt","year":"2017","journal-title":"Semin Reprod Med"},{"key":"2020033016151233900_ref30","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1093\/humupd\/dmy022","article-title":"Understanding variation in prevalence estimates of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"24","author":"Skiba","year":"2018","journal-title":"Hum Reprod Update"},{"key":"2020033016151233900_ref31","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41591-018-0035-5","article-title":"Elevated prenatal anti-Mullerian hormone reprograms the fetus and induces polycystic ovary syndrome in adulthood","volume":"24","author":"Tata","year":"2018","journal-title":"Nat Med"},{"key":"2020033016151233900_ref32","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5694\/mja18.00656","article-title":"Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary Syndrome","volume":"209","author":"Teede","year":"2018","journal-title":"Med J Aust"},{"key":"2020033016151233900_ref33","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1093\/humrep\/dey256","article-title":"International PCOS Network. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"2020033016151233900_ref34","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.5694\/mja11.10915","article-title":"Guideline Development Group. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline","volume":"195","author":"Teede","year":"2011","journal-title":"Med J Aust"},{"key":"2020033016151233900_ref35","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/humrep\/deh098","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)","volume":"19","author":"The Rotterdam ESHRE\/ASRM PCOS Workshop","year":"2004","journal-title":"Hum Reprod"},{"key":"2020033016151233900_ref36","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1093\/humrep\/dew287","article-title":"The Rotterdam criteria for polycystic ovary syndrome: evidence-based criteria?","volume":"32","author":"Wang","year":"2017","journal-title":"Hum Reprod"},{"key":"2020033016151233900_ref37","first-page":"377","volume-title":"Polycystic Ovary Syndrome","author":"Zawadzki","year":"1992"}],"container-title":["Human Reproduction"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/3\/660\/32981018\/deaa005.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humrep\/article-pdf\/35\/3\/660\/32981018\/deaa005.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T16:15:46Z","timestamp":1585584946000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humrep\/article\/35\/3\/660\/5754094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,26]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2,26]]},"published-print":{"date-parts":[[2020,3,27]]}},"URL":"https:\/\/doi.org\/10.1093\/humrep\/deaa005","relation":{},"ISSN":["0268-1161","1460-2350"],"issn-type":[{"value":"0268-1161","type":"print"},{"value":"1460-2350","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,3]]},"published":{"date-parts":[[2020,2,26]]}}}